18 results
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents ... #Dosing #Oral #Anticoagulation ... #Comparison #Table
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
and prevention - Comparison ... Table #DOAC ... Anticoagulants #Anticoagulation ... #VTE #Management ... #Table
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage

The table summarizes the recommendations for adult patients on
Hemorrhage The table ... anti-thrombotic agents ... Antiplatelet Agent ... Antithrombotics #Anticoagulation ... IntracranialHemorrhage #ICH #Management
On the left some diseases with a nodular pattern.
1. Hypersensitivity pneumonitis: ill defined centrilobular nodules.
2. Miliary
with a nodular pattern ... CTChest #Nodular #Pattern ... #NodularPattern ... #Differential #Comparison ... #Table #RadiologyAssistant
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... anti-hyperglycemic agents ... anti-hyperglycemic agents ... pharmacotherapy #table ... #comparison #management
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pharmacologic Pain Management ... steroids, on ASA/anticoagulation ... • Neuropathic agents ... #pharmacology #agents ... internship #guide #comparison
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... - Dabigatran #anticoagulation ... medications #doac #comparison ... #table #management
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... major adverse CV events ... major adverse CV events ... #medications #table ... #comparison #management
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
Replacement - Anticoagulation ... valves since these agents ... 2.4.3; UpToDate Anticoagulation ... #Management #Cardiology ... #Target #DOAC #Table
Evans Syndrome Pharmacology Management 
Corticosteroids
IVIg
Rituximab
Splenectomy
Azathioprine
Cyclophosphamide
Cyclosporin
Mycophenolate
Vinka-alkaloid
Plasma exchange
Transfusion
Anticoagulation
Bone marrow stimulating agents

doi:10.3390/jcm9123851

#Evans #Syndrome #Pharmacology #Management #Medications #comparison #table
Syndrome Pharmacology Management ... exchange Transfusion Anticoagulation ... marrow stimulating agents ... #Medications #comparison ... #table